期刊文献+

49例急性白血病细胞遗传学分析 被引量:3

Cytogenetical analysis of 49 patients with acute leukemia
下载PDF
导出
摘要 目的应用细胞遗传学分析方法研究急性白血病染色体异常特征,结合临床探讨细胞遗传学对急性白血病诊治的价值。方法采用短期培养法制备骨髓细胞染色体,以G显带对49例急性白血病患者进行染色体核型分析,并观察30例接受联合化疗患者的临床转归。结果49例初诊为急性白血病患者中,细胞核型异常检出率73%(36/49)。联合化疗30例中,首次住院达完全缓解者19例(63%)。核型正常及典型t(15;17)易位者疗效较好,核型异常如t(9;22)、t(5;17)等易位者疗效较差。结论半数以上急性白血病患者可检出克隆性染色体异常,其中,特异性染色体重排与特定的白血病亚型相关。细胞遗传学改变是影响白血病预后的因素。 Objective To analyze the karyotype of the patient with acute leukemia,and investigate the value of cytogenetic exam- ination in diagnosis and treatment of acute leukemia. Methods Cytogenetic examination of bone marrow cells was performed by short-turn culture method. G banding technique was used for karyotype analysis. 30 patients accepted combined chemotherapy. Their response and survival rate were analyzed. Results Cytogenetical abnormalities were found in 36 of 49 acute leukemia cases. The total rate of chromosomal abnormality was 73%. In all the 30 cases accepted chemotherapy, the complete remission rate was 63 % (19/30). Patients with normal karyotype and typical t(15;17) showed a better response to chemotherapy than cases with aberrant karyotype such as t(9 ;22) and t(5 ; 17) etc. Conclusion Abnormal karyotype can be found in more than half of the acute leukemia cases. Some recurrent genetic abnormalities are usually associated with speeifical type of leukemia. Genetic abnormality is a factor influences the treatment response of acute leukemia.
出处 《重庆医学》 CAS CSCD 2008年第18期2057-2059,共3页 Chongqing medicine
关键词 急性白血病 染色体 化疗 acute leukemia chromosome chemotherapy
  • 相关文献

参考文献6

  • 1薛永权.细胞遗传学改变在恶性血液病诊断与预后中的意义[J].诊断学理论与实践,2004,3(6):401-405. 被引量:10
  • 2Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML.. analysis of 612 patients entered into the MRC AML 10 trial[J]. Blood ; 1998,92(7): 2322.
  • 3Harris NL,Jaffe ES. The world health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues:report of the clinical advisory committee meeting. Airlie House, Virginia, November 1997 [J]. Ann Oneol, 1999,10 : 1419.
  • 4Xin L,Wan-jun S. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center[J]. Leuk Res, 2007,31 (6) : 765.
  • 5Andersen MK,Larson RA. Balanced chromosome abnor realities inv(16) and t(15; 17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop[J]. Genes Chrom Cancer, 2002,33 (4) :395.
  • 6Killick S, Matures E, Powles RL, et al. Outcome of biphenotypie acute leukemia[J]. Haematologica, 1999,84 : 699.

二级参考文献20

  • 1[1]Sandberg AA. The chromosome in human cancer and leukemia[M]. New York: Elsevier North Holland, 1980,349-353.
  • 2[2]Bernstein R.Cytogenetics of chronic myelogenous leukemia [J]. Semin Hematol, 1988, 25 (1): 20-34.
  • 3[3]Guilhot F, Chastang C, Michallet M, et al. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia[J]. N Eng J Med, 1997,337(4): 223-229.
  • 4[4]Druker B J, Lydon NB. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia[J]. J Clin Invest, 2000, 105 (1): 3-7.
  • 5[5]Travis LB, Pierre RV, Dewald GW. Ph-negative chronic granulocytic leukemia: a nonentity[J]. Am J Clin Pathol,1986, 85(2): 186-193.
  • 6[6]Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia[J]. Semin Oncol, 1998, 25(1): 19-26.
  • 7[7]Diedamm J, Michaux L, Criel A, et al. Genetic abnormalities in chronic lymphocytic leukemia and their clinical prognostic implication[J]. Cancer Genet Cytogenet, 1997,94(1): 27-35.
  • 8[8]Jaffe ES, Harris NL, Stein H, et al. World Health Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M]. IARL Press: Lyon, 2001. 15-44.
  • 9[9]Caligiuri MA, Strout MP, Gillilard DG. Molecular biology of acute myeloid leukemia[J]. Semin Oncol, 1997, 24(1):32-44.
  • 10[10]Melnick A, Licht JD. Deconstructing a disease: RAR alpha, its fusion partners and their roles in the pathogenesis of acute promyelocytic leukemia[J]. Blood, 1999,93(10): 3167-3215.

共引文献9

同被引文献20

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部